The protective effects of Alda-1, which enhances ALDH2 detoxification activity and mitigates hepatic lipid content, hint at potential interventions that could target ALDH2-related dysregulation in MASLD [40]. This evidence concerns the gene ALDH2 and metabolic dysfunction-associated steatotic liver disease.